These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 11687986)

  • 1. [Problems in everyday practice: ventricular extrasystoles].
    Schoels W; Bethge KP; Brachmann J; Gonska BD; Jung W; Wehr M
    Dtsch Med Wochenschr; 2001 Nov; 126(44):1245-8. PubMed ID: 11687986
    [No Abstract]   [Full Text] [Related]  

  • 2. [Ventricular extrasystole: prognostic value and therapeutic indication].
    Voiriot P; Aliot E; Gilgenkrantz JM
    Ann Cardiol Angeiol (Paris); 1984; 33(2):99-107. PubMed ID: 6201123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonsustained ventricular tachycardia.
    Buxton AE; Duc J; Berger EE; Torres V
    Cardiol Clin; 2000 May; 18(2):327-36, viii. PubMed ID: 10849876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Sustained monomorphic ventricular tachycardia in non ischemic heart diseases].
    Frank R; Lascault G; Tonet J; Aouate P; Fontaine G
    Arch Mal Coeur Vaiss; 1993 May; 86(5 Suppl):753-6. PubMed ID: 8267503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [14-year experience with implantable cardioverter/defibrillators: determination of prognosis and discharge behavior].
    Vester EG; Dees H; Dobran I; Hennersdorf M; Perings C; Heydthausen M; Winter J; Strauer BE
    Z Kardiol; 2000; 89 Suppl 3():194-205. PubMed ID: 10810803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cardiomyopathies: mortality, sudden death, and ventricular arrhythmias.
    Leier CV
    Cardiovasc Clin; 1992; 22(1):275-306. PubMed ID: 1728430
    [No Abstract]   [Full Text] [Related]  

  • 7. Risk assessment and prevention of sudden cardiac death in hypertrophic cardiomyopathy.
    Slade AK; Camm AJ
    Arch Mal Coeur Vaiss; 1996 Feb; 89 Spec No 1():37-49. PubMed ID: 8734163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Catheter ablation of symptomatic ventricular extrasystoles in patients without structural heart disease].
    Geller JC; Reek S; Klein HU
    Dtsch Med Wochenschr; 2002 Nov; 127(48):2566-9. PubMed ID: 12457327
    [No Abstract]   [Full Text] [Related]  

  • 9. [Ambulatory ECG in cardiomyopathies].
    Mestroni L; Miani D; Neri R; Di Lenarda A; Camerini F
    G Ital Cardiol; 1987 Dec; 17(12):1139-44. PubMed ID: 3503812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Ventricular extrasystoles].
    Leenhardt A; Extramiana F; Milliez P; Meddane M; Haggui A; Cauchemez B
    Arch Mal Coeur Vaiss; 2004 Dec; 97 Spec No 4(4):7-12. PubMed ID: 15714885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tachycardia in a patient with hypertrophic cardiomyopathy and suspected ventricular preexcitation.
    Dyrda K; Fournier A; Marcotte F; Khairy P
    Pacing Clin Electrophysiol; 2011 Jan; 34(1):104-6. PubMed ID: 20636315
    [No Abstract]   [Full Text] [Related]  

  • 12. Malignant mitral valve prolapse: an uncommon variation of a common condition.
    Joyce T; Ferns S
    BMJ Case Rep; 2020 Oct; 13(10):. PubMed ID: 33109691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical electrophysiology of ventricular tachycardia.
    Prystowsky EN; Heger JJ; Lloyd EA; Zipes DP
    Cardiol Clin; 1983 May; 1(2):253-73. PubMed ID: 6544638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atrial fibrillation degenerates into ventricular fibrillation.
    Venkataraman G; Strickberger SA
    J Am Coll Cardiol; 2010 Mar; 55(10):1050. PubMed ID: 20202524
    [No Abstract]   [Full Text] [Related]  

  • 15. Noninvasive arrhythmia risk stratification in idiopathic dilated cardiomyopathy: results of the Marburg Cardiomyopathy Study.
    Grimm W; Christ M; Bach J; Müller HH; Maisch B
    Circulation; 2003 Dec; 108(23):2883-91. PubMed ID: 14623812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amiodarone versus implantable cardioverter defibrillator for asymptomatic nonsustained ventricular tachycardia in nonischemic dilated cardiomyopathy.
    Cawley PJ; Al-Khatib SM
    Am Heart J; 2004 May; 147(5):790-1. PubMed ID: 15131532
    [No Abstract]   [Full Text] [Related]  

  • 17. [Therapy of hypertrophic cardiomyopathy].
    Cecchi F; Olivotto I
    G Ital Cardiol; 1999 Oct; 29(10):1199-203. PubMed ID: 10546134
    [No Abstract]   [Full Text] [Related]  

  • 18. [Task Force on Sudden Cardiac Death, European Society of Cardiology. Summary of recommendations].
    Priori SG; Aliot E; Blømstrom-Lundqvist C; Bossaert L; Breithardt G; Brugada P; Camm JA; Cappato R; Cobbe SM; Di Mario C; Maron BJ; McKenna WJ; Pedersen AK; Ravens U; Schwartz PJ; Trusz-Gluza M; Vardas P; Wellens HJ; Zipes DP;
    Ital Heart J Suppl; 2002 Oct; 3(10):1051-65. PubMed ID: 12478833
    [No Abstract]   [Full Text] [Related]  

  • 19. Sudden death and hypertrophic cardiomyopathy: a review.
    Ly HQ; Greiss I; Talakic M; Guerra PG; Macle L; Thibault B; Dubuc M; Roy D
    Can J Cardiol; 2005 Apr; 21(5):441-8. PubMed ID: 15861263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [How do I diagnose and treat ventricular extrasystoles?].
    Raatikainen MJ; Yli-Mäyry S; Huikuri HV
    Duodecim; 2002; 118(2):145-54; quiz 154, 208. PubMed ID: 12229109
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.